The activity level of follicular helper T cells in the peripheral blood of osteosarcoma patients is associated with poor prognosis

References

• ElKordy MA, ElBaradie TS, ElSebai HI, et al. Osteosarcoma of the jaw: challenges in the diagnosis and treatment. J Egypt Natl Canc Inst. 2018;30:7–11.
   PubMed Web of Science ®Google Scholar
• Guan H, Mei Y, Mi Y, et al. Downregulation of lncRNA ANRIL suppresses growth and metastasis in human osteosarcoma cells. Onco Targets Ther. 2018;11:4893–4899.
   PubMed Web of Science ®Google Scholar
• Simpson E, Brown HL. Understanding osteosarcomas. Jaapa. 2018;31:15–19.
   PubMedGoogle Scholar
• Anderson ME. Update on survival in Osteosarcoma. Orthop Clin North Am. 2016;47:283–292.
   PubMed Web of Science ®Google Scholar
• Liu YJ, Li W, Chang F, et al. MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion. Oncol Rep. 2018;39:491–500.
   PubMed Web of Science ®Google Scholar
• Fleuren ED, Versleijen-Jonkers YM, Boerman OC, et al. Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: current hurdles and future perspectives. Biochim Biophys Acta. 2014;1845:266–276.
   PubMed Web of Science ®Google Scholar
• Wu Z, Liu J, Hu S, et al. Serine/Threonine Kinase 35, a target gene of STAT3, regulates the proliferation and apoptosis of Osteosarcoma cells. Cell Physiol Biochem. 2018;45:808–818.
   PubMedGoogle Scholar
• Adamopoulos C, Gargalionis AN, Piperi C, et al. Recent advances in mechanobiology of Osteosarcoma. J Cell Biochem. 2017;118:232–236.
   PubMed Web of Science ®Google Scholar
• Agarwal M, Anchan C, Shah M, et al. Limb salvage surgery for osteosarcoma: effective low-cost treatment. Clin Orthop Relat Res. 2007;459:82–91.
   PubMedGoogle Scholar
• Lettieri CK, Appel N, Labban N, et al. Progress and opportunities for immune therapeutics in osteosarcoma. Immunotherapy. 2016;8:1233–1244.
   PubMed Web of Science ®Google Scholar
• Liu R, Hu Y, Liu T, et al. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer. BMC Cancer. 2021;21:1345.
   PubMed Web of Science ®Google Scholar
• Mintz MA, Cyster JG. T follicular helper cells in germinal center B cell selection and lymphomagenesis. Immunol Rev. 2020;296:48–61.
   PubMed Web of Science ®Google Scholar
• Fazilleau N, Mark L, McHeyzer-Williams LJ, et al. Follicular helper T cells: lineage and location. Immunity. 2009;30:324–335.
   PubMed Web of Science ®Google Scholar
• Linterman MA, Rigby RJ, Wong RK, et al. Follicular helper T cells are required for systemic autoimmunity. J Exp Med. 2009;206:561–576.
   PubMed Web of Science ®Google Scholar
• Shin D, Kim DS, Kim SH, et al. Decreased PD-1 positive blood follicular helper T cells in patients with psoriasis. Arch Dermatol Res. 2016;308:593–599.
   PubMed Web of Science ®Google Scholar
• Fazilleau N, McHeyzer-Williams LJ, Rosen H, et al. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol. 2009;10:375–384.
   PubMed Web of Science ®Google Scholar
• Odegard JM, Marks BR, DiPlacido LD, et al. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J Exp Med. 2008;205:2873–2886.
   PubMed Web of Science ®Google Scholar
• Ohmatsu H, Sugaya M, Fujita H, et al. Primary cutaneous follicular helper T-cell lymphoma treated with allogeneic bone marrow transplantation immunohistochemical comparison with angioimmunoblastic T-cell lymphoma. Acta Derm Venereol. 2014;94:54–57.
   PubMed Web of Science ®Google Scholar
• Song H, Liu A, Liu G, et al. T follicular regulatory cells suppress Tfh-mediated B cell help and synergistically increase IL-10-producing B cells in breast carcinoma. Immunol Res. 2019;67:416–423.
   PubMed Web of Science ®Google Scholar
• Gao W, Zhou J, Ji B. Evidence of Interleukin 21 reduction in Osteosarcoma patients due to PD-1/PD-L1-mediated suppression of follicular helper T cell functionality. DNA Cell Biol. 2017;36:794–800.
   PubMed Web of Science ®Google Scholar
• Mahnke YD, Beddall MH, Roederer M. OMIP-017: human CD4(+) helper T-cell subsets including follicular helper cells. Cytometry A. 2013;83:439–440.
   PubMedGoogle Scholar
• Jiang B, Kang X, Zhao G, et al. miR-138 reduces the dysfunction of T follicular helper cells in Osteosarcoma via the PI3K/Akt/mTOR pathway by targeting PDK1. Comput Math Methods Med. 2021;2021:2895893.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liang J, Jiang S, et al. The Effect of miR-138 on the function of follicular helper T cells and the differentiation of B cells in Osteosarcoma. Comput Math Methods Med. 2021;2021:2057782.
   PubMed Web of Science ®Google Scholar
• Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21(Suppl 7):vii320–5.
   PubMed Web of Science ®Google Scholar
• Morita R, Schmitt N, Bentebibel SE, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34:108–121.
   PubMed Web of Science ®Google Scholar
• Cao G, Wang P, Cui Z, et al. An imbalance between blood CD4(+)CXCR5(+)Foxp3(+) Tfr cells and CD4(+)CXCR5(+)Tfh cells may contribute to the immunopathogenesis of rheumatoid arthritis. Mol Immunol. 2020;125:1–8.
   PubMed Web of Science ®Google Scholar
• Zhou M, Zou R, Gan H, et al. Erratum to: the effect of aging on the frequency, phenotype and cytokine production of human blood CD4 + CXCR5 + T follicular helper cells: comparison of aged and young subjects. Immun Ageing. 2015;12:13.
   PubMed Web of Science ®Google Scholar
• Jenkin RD, Allt WE, Fitzpatrick PJ. Osteosarcoma. An assessment of management with particular reference to primary irradiation and selective delayed amputation. Cancer. 1972;30:393–400.
   PubMed Web of Science ®Google Scholar
• Tsuchiya H, Kanazawa Y, Abdel-Wanis ME, et al. Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: the Japanese Musculoskeletal Oncology Group study. J Clin Oncol. 2002;20:3470–3477.
   PubMed Web of Science ®Google Scholar
• Chen C, Xie L, Ren T, et al. Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs. Cancer Lett. 2021;500:1–10.
   PubMed Web of Science ®Google Scholar
• Peng W, Ye Y, Rabinovich BA, et al. Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses. Clin Cancer Res. 2010;16:5458–5468.
   PubMed Web of Science ®Google Scholar
• Linterman MA, Liston A, Vinuesa CG. T-follicular helper cell differentiation and the co-option of this pathway by non-helper cells. Immunol Rev. 2012;247:143–159.
   PubMed Web of Science ®Google Scholar
• Vinuesa CG, Linterman MA, Yu D, et al. Follicular helper T cells. Annu Rev Immunol. 2016;34:335–368.
   PubMed Web of Science ®Google Scholar
• Wang J, Shan Y, Jiang Z, et al. High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis. Clin Exp Immunol. 2013;174:212–220.
   PubMed Web of Science ®Google Scholar
• Zhang C, Chakravarty D, Sakabe I, et al. Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther. 2006;13:947–955.
   PubMed Web of Science ®Google Scholar
• Laliberté B, Wilson AM, Nafisi H, et al. TNFAIP8: a new effector for Galpha(i) coupling to reduce cell death and induce cell transformation. J Cell Physiol. 2010;225:865–874.
   PubMed Web of Science ®Google Scholar
• Perreau M, Savoye AL, De Crignis E, et al. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med. 2013;210:143–156.
   PubMed Web of Science ®Google Scholar
• Stebegg M, Kumar SD, Silva-Cayetano A, et al. Regulation of the germinal center response. Front Immunol. 2018;9:2469.
   PubMed Web of Science ®Google Scholar
• Guo Z, Liang H, Xu Y, et al. The role of circulating T follicular helper cells and regulatory cells in non-small cell lung cancer patients. Scand J Immunol. 2017;86:107–112.
   PubMed Web of Science ®Google Scholar
• Cha Z, Gu H, Zang Y, et al. The prevalence and function of CD4(+)CXCR5(+)Foxp3(+) follicular regulatory T cells in diffuse large B cell lymphoma. Int Immunopharmacol. 2018;61:132–139.
   PubMed Web of Science ®Google Scholar
• Li L, Ma Y, Xu Y. Follicular regulatory T cells infiltrated the ovarian carcinoma and resulted in CD8 T cell dysfunction dependent on IL-10 pathway. Int Immunopharmacol. 2019;68:81–87.
   PubMed Web of Science ®Google Scholar